KERAGRAF owner Contact Information online
from SMITH & NEPHEW, INC.
KERAGRAF
US serial number:85083351
Application filling date:Jul. 13, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Feb. 17, 2014
Publication date:Nov. 16, 2010
Abandoned date:Feb. 17, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations, namely, tissue equivalents, grafts, and matrices, for the treatment of wounds, burns, and dermatological conditions and diseases
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Sta
Services:Pharmaceutical preparations
namely
tissue equivalents
grafts
and matrices
for the treatment of wounds
burns
and dermatological conditions and diseases
Current owner owner name:SMITH & NEPHEW, INC.
Current owner owner address:1450 BROOKS ROAD
MEMPHIS,
TENNESSEE
UNITED STATES
38116
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:William D. Wiese
Attorney email:bwiese@dbcllp.com
Attorney docket number:2386-686USTM
Attorney email authorized:Yes
Correspondent name address:WILLIAM D. WIESE
DUBOIS, BRYANT & CAMPBELL, LLP
700 LAVACA ST STE 1300
AUSTIN,
TEXAS
UNITED STATES
78701-3104
Correspondent phone:512.457.8000
Correspondent email:bwiese@dbcllp.com
Correspondent fax:512.457.8008
Correspondent email authorized:Yes
Trademark staff tm attorney:I, DAVID C
Trademark staff law office assigned KERAGRAF:LAW OFFICE 114
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) S. C. Johnson & Son, Inc. (31) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Nov. 16, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
